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Abstract Objective: To test the
hypothesis that RBC transfusion in
critically ill children is independently
associated with increased mortality
and morbidity. Design: Retro-
spective, descriptive epidemiologic
cohort study. Setting: Single-center
experience of a nine-bed pediatric
intensive care unit (PICU) facility.
Patients: Critically ill children with-
out ongoing active blood loss aged
0 months to 18 years, excluding pre-
maturely born infants or patients after
cardiothoracic surgery, and patients
with chronic anemia. Interventions:
None. Measurements and Results:
Data of 295 consecutive patients was
studied. Of these patients, 13.4% had
a Hb concentration less than 9.6 g/dl.
Sixty-seven (22.7%) of all patients
were transfused, 39 only once. Trans-
fused patients had a higher mortality
(16.4 vs. 2.6%, p < 0.001). Mortality
seemed related to the number of
transfusion (p = 0.002) rather than
the pre-transfusion Hb concentra-
tion (p = 0.10). Transfused patients
required prolonged ventilatory sup-
port (11.1 ± 1.8 vs. 3.2 ± 0.3 days,
p < 0.001), infusion of vaso-active
agents (8.2 ± 1.8 vs. 2.8 ± 0.6 days,
p < 0.001) and PICU stay (13.0 ± 1.8
vs. 3.2 ± 0.2 days, p < 0.001). After
multivariate analysis adjusting for
age, PIM probability of death, mean
TISS-28 score during the first 48 h,
post-operative admission, diagnosis
of sepsis or trauma or malignancy,
pre-transfusion Hb concentration,
and RBC transfusion remained inde-
pendently associated with mortality
and morbidity. Conclusions: RBC
transfusion in critically ill children
is independently associated with
increased mortality and prolonged
duration of mechanical ventilation,
prolonged infusion of vaso-active
agents and prolonged PICU stay.
Keywords Critically ill children ·
Erythrocyte transfusions · Mortality ·
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Introduction
The practice of red blood cell (RBC) transfusion in
critically ill children is common [1–3]. From a retro-
spective survey among five pediatric intensive care units
(PICU) in the United States it was found that 54.5%
of all children with a pre-transfusion hemoglobin (Hb)
concentration below 9 g/dl received one or more RBC
transfusions [4]. Nevertheless, a well-defined threshold
value of hemoglobin (Hb) used for the decision as to when
to transfuse or not is unavailable [5].
An increasing number of prospective and retrospec-
tive (observational) studies in a heterogeneous group
of critically ill adults show that RBC transfusions are
independently associated with increased morbidity
and mortality, irrespective of disease severity defined
by admitting APACHE II and SOFA scores [6–16]. It
is unknown whether this is also true for critically ill
children.
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The objective of our observational study therefore was
to test the hypothesis that RBC transfusion in a heteroge-
neous group of critically ill children admitted to a medico-
surgical pediatric ICU (PICU) is independently associated
with increased mortality and morbidity, irrespective of pre-
transfusion Hb and disease severity.
Materials and methods
Study design
The study was designed as a retrospective, single-center
observational study. The need for informed consent was
waived by the institutional review board.
Patients and setting
Records from all children aged 0 months to 18 years
admitted to the PICU of our hospital were obtained,
irrespective of pre-transfusion Hb concentration. We
chose to study patients admitted between January and
December 2003, because as of January 2002 all RBC
concentrates were leukocyte-depleted in The Netherlands.
Anemia was defined by a Hb concentration below 9.6 g/dl
as described previously [1, 17]. Children diagnosed with
chronic anemia (defined by the presence of anemia for
more than 6 weeks), children with hemoglobinopathies,
and children with active blood loss were excluded. Our
PICU is a combined medical and surgical tertiary nine-bed
facility that includes all specialties except the care for
prematurely born infants (these patients are admitted
to the neonatal intensive care unit of our hospital) and
patients after cardiothoracic surgery.
Data collection
For each patient demographical and clinical data, includ-
ing type of admission, primary diagnostic category, his-
tory of anemia and recent acute blood loss, pre-transfusion
hemoglobin (Hb) concentration or first Hb concentration
for non-tranfused patients, number of erythrocyte trans-
fusions, and volume transfused, was noted. Our unit did
not have a transfusion guideline. The decision to trans-
fuse a patient was made by the attending physician. Rou-
tinely, the quantity per erythrocyte transfusion amounts to
10–15 ml/kg.
Disease severity upon PICU admission was defined by
the Pediatric Index of Mortality (PIM) probability of death.
The PIM score is composed of variables that are noted dur-
ing the first hour of PICU admission. For this study the
PIM score was retrospectively calculated. Data on all vari-
ables necessary for this score were available in all patients.
This score reflects the severity of disease and have been
validated [18]. Additionally, the TISS-28 score was cal-
culated for the first 2 days of PICU admission. TISS-28 is
a scoring system composed of 28 therapeutic activities that
can be used to assess severity of illness [19]. The TISS-28
score is prospectively calculated on a daily basis in our
unit.
Definition of outcome
The PICU mortality was the primary outcome. Morbid-
ity as secondary outcome was defined by duration of me-
chanical ventilation (MV), duration of infusion of vaso-
active agents including dopamine, dobutamine, and nore-
pinephrine, and duration of PICU stay.
Statistical analysis
In the univariate analysis demographical and clinical data
were compared between patients who were transfused and
those who were not. For continuous variables the Mann-
Whitney U-test was used, and for categorical variables the
χ2 test or Fisher’s exact test. Missing variables were not
imputed.
Subsequently, we wanted to the estimate the indepen-
dent contribution of RBC transfusion to each outcome
parameter. We therefore applied multiple logistic re-
gression analysis for the primary outcome (mortality,
which is dichotomous data), and Cox proportional hazards
regression analysis for the secondary outcome measures
(duration of infusion of vaso-active agents, mechanical
ventilation and PICU stay, which are continuous data).
Regression analysis estimates how confounders are related
to the outcome and produces an adjusted estimate of the
intervention effect [20]. To adjust for disease severity
upon PICU admission, we adjusted for PIM probability
of death. To adjust for confounding by indication, we
adjusted for the mean TISS-28 score during the first 48 h
after PICU admission. Finally, we also adjusted for pre-
transfusion Hb concentration, admission post-operatively,
and admission diagnosis. Each potential confounding
variable was separately entered into the model.
To study if RBC transfusion would lead to an excess
in mortality, we also calculated the Standardized Mortality
Ratio (SMR) for five probability of death strata calculated
from the PIM score. The SMR is calculated by dividing
the observed number of deaths by the expected number of
deaths per strata. The expected number of deaths was ob-
tained from the Dutch Working Group on Pediatric Inten-
sive Care Evaluation (PICE).
All statistical analyses were performed with SPSS ver-
sion 13 (Chicago, Ill.). The p-values below 0.05 were ac-
cepted as statistically significant. Data are expressed as
mean ± standard error unless otherwise stated.
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Results
Description of the study population
During the study period a total number of 295 consecu-
tive patients were admitted. No patients met the exclusion
criteria. In addition, there were no patients with ongoing
active blood loss as cause of anemia.
One hundred sixteen patients (39.3%) were admitted
after a surgical procedure. Mechanical ventilation was
required in 123 patients (41.7%). Forty-two (14.2%)
patients required continuous infusion of vaso-active
Table 1 Differences in unadjusted analysis between patients who
received one or more red blood cell (RBC) transfusions and patients
who were not transfused. PIM, Pediatric Index of Mortality;
IQR, interquartile range. Continuous variables are presented as
mean ± standard error, categorical variables are presented as
absolute number (n) or frequency (%)
RBC transfusion p-value
Yes (n = 67) No (n = 228)
Age (months), median (25-75 IQR) 65.4 ± 8.0 (38.9; 8.3–115.1) 71.4 ± 11.7 (29.2; 4.0–112.6) 0.336
Boys/girls (%) 59.7/40.3 58.3/41.7 0.842
PIM probability of death (%) 4.6 ± 1.1 1.7 ± 0.3 < 0.001
Mean TISS during first 48 h 24 ± 2 15 ± 1 < 0.001
Hemoglobin (g/dl) a, median (25–75 IQR) 9.6 ± 0.2 (9.3; 8.2–10.6) 13.0 ± 0.2 (12.4; 11.0–13.7) < 0.001
Admission diagnosis (n) b
Post-operative 23 93 0.41
Infectious diseases c 22 59 0.26
Trauma 9 13 0.034
Septic shock 4 3 0.05
Malignancy 6 7 0.039
Miscellaneous 3 54 < 0.001
a For transfused patients the number represents the pre-transfusion Hb, for non-transfused patients it represents Hb at admission; b When
the count of any cell was below five, the Fisher’s exact test was used; c Included all infectious causes irrespective of organ system
Table 2 Results from unadjusted analysis on the primary and secondary outcomes. PICU, pediatric intensive care unit. Continuous variable
are presented as mean ± standard error, categorical variables are presented as frequency (%)
No. of patients RBC No RBC p-value
(transfused/not transfused) transfusion transfusion
All patients (n = 295)
Vaso-active support (days) 27/15 8.2 ± 1.8 2.8 ± 0.6 0.043
Mechanical ventilation (days) 59/64 11.1 ± 1.8 3.2 ± 0.3 < 0.001
PICU stay (days) 67/228 13.0 ± 1.8 3.2 ± 0.2 < 0.001
Mortality (%) 67/228 16.4 2.6 < 0.001
Patients not admitted post-operatively (n = 179)
Vaso-active support (days) 20/12 7.7 ± 1.9 3.2 ± 2.4 0.083
Mechanical ventilation (days) 39/39 11.5 ± 2.2 3.6 ± 0.5 < 0.001
PICU stay (days) 44/135 14.1 ± 2.2 3.6 ± 0.3 < 0.001
Mortality (%) 44/135 15.9 4.4 0.011
Patients with a PICU stay > 2 days (n = 133)
Vaso-active support (days) 23/8 9.5 ± 1.9 4.0 ± 0.9 0.219
Mechanical ventilation (days) 48/40 13.4 ± 2.0 3.8 ± 0.5 < 0.001
PICU stay (days) 51/82 16.5 ± 2.1 5.4 ± 0.4 < 0.001
Mortality (%) 51/82 17.6 3.7 0.006
Patients without a high-risk diagnosis (sepsis and/or malignancy; n = 278)
Vaso-active support (days) 21/15 8.2 ± 2.1 2.8 ± 0.6 0.096
Mechanical ventilation (days) 52/64 11.4 ± 1.9 3.2 ± 0.3 < 0.001
PICU stay (days) 57/221 12.9 ± 2.0 3.2 ± 0.2 < 0.001
Mortality (%) 57/221 15.8 2.7 < 0.001
agents. Data on pre-transfusion Hb or first Hb upon PICU
admission could be retrieved in 261 (88.5%) patients.
Anemia occurred in 13.8% of all patients. Severe anemia
(Hb < 7 g/dl) occurred in 7 (2.7%) of all patients. Sixty-
seven (22.7%) patients were transfused; 39 (58.2%) were
transfused only once. Seventeen patients (5.8%) died.
Univariate analysis
Table 1 summarizes the differences in demographical
and clinical variables between patients who received
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Fig. 1 Differences in survival by
pre-transfusion Hb, or first Hb if
not transfused. [Data on
pre-transfusion Hb or first Hb
upon PICU admission available
in 261 (88.5%) patients]
Table 3 Results from the logistic regression analysis on the asso-
ciation between RBC transfusion and mortality. Adjustments were
made for PIM probability of death, mean TISS-28 score during the
first 48 h of PICU admission, post-operative admission, presence of
sepsis and/or malignancy, and pre-transfusion hemoglobin concen-
tration. OR, odds ratio; CI, confidence interval of the OR
Variable Odds ratio 95% CI p-value
Full model
PIM probability of death 1.087 1.019–1.159 0.011
Mean TISS-28 1.043 0.978–1.113 0.202
Sepsis and/or malignancy 1.103 0.092–13.161 0.938
Post-operative admission 0.845 0.178–4.011 0.832
Pre-transfusion Hb (g/dl) 1.228 0.944–1.597 0.125
RBC transfusion 9.951 1.283–77.157 0.028
Bivariate analysis
Adjusting for PIM probability of death (n = 295)
PIM probability of death 1.097 1.033–1.165 0.002
RBC transfusion 5.730 1.892–17.351 0.002
Adjusting for mean TISS-28 during the first 48 h of PICU admission (n = 295)
Mean TISS-28 1.036 0.979–1.096 0.224
RBC transfusion 4.699 1.144–19.302 0.032
Adjusting for presence of sepsis and/or malignancy (n = 295)
Sepsis and/or malignancy 1.134 0.220–5.839 0.881
RBC transfusion 7.157 2.486–20.603 < 0.001
Adjusting for post-operative admission (n = 295)
Post-operative admission 0.495 0.153–1.603 0.241
RBC transfusion 7.065 2.496–20.001 < 0.001
Adjusting for pre-transfusion Hb (n = 261)
Pre-transfusion Hb (g/dl) 1.106 0.776–1.577 0.576
RBC transfusion 9.309 2.369–36.587 0.001
Hosmer and Lemeshow Goodness-of-fit test for the full model, χ2 test 4.308 with 8 degrees of freedom, p = 0.828
one or more RBC transfusions and those who were not
transfused. Gender distribution and mean age were not
different between the two groups. We noted a significantly
higher mean PIM probability of death among transfused
patients, indicating that they were more severely ill. We
also found a significantly higher mean TISS-28 score
during the first 48 h of PICU admission.
Table 2 summarizes the difference between patients
with and without RBC transfusion on primary and sec-
ondary outcome measures. Among patients who had
received one or more RBC transfusions a higher mortality
rate (16.4 vs. 2.6%, p < 0.001) was observed. Importantly,
we observed no association between the pre-transfusion
Hb concentration and mortality (p = 0.10) as can be seen
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Fig. 2 Differences in survival by
number of red blood cell
transfusions
Variable Hazard 95% CI p-value
PIM probability of death (%) 0.979 0.889–1.078 0.665
Mean TISS-28 first 48 h 1.022 0.990–1.055 0.175
Pre-transfusion Hb concentration (mmol/l) 0.956 0.214–4.277 0.954
Post-operative admission (yes/no) 0.693 0.226–2.122 0.521
Presence of sepsis/malignancy (yes/no) 1.012 0.799–1.283 0.918
RBC transfusion 3.366 1.111–10.198 0.032
Table 4 Results from the Cox
proportional hazards regression
analysis on the association
between RBC transfusion and
duration of infusion of
vaso-active agents (n = 42
patients). Adjustments were
made for age, PIM probability of
death, mean TISS-28 score
during the first 48 h of PICU
admission, post-operative





Variable Hazard 95% CI p-value
PIM probability of death (%) 0.971 0.913–1.033 0.356
Mean TISS-28 first 48 h 1.006 0.989–1.023 0.505
Pre-transfusion Hb concentration (mmol/l) 1.004 0.335–3.004 0.995
Post-operative admission (yes/no) 0.782 0.486–1.257 0.310
Presence of sepsis/malignancy (yes/no) 0.981 0.897–1.073 0.672
RBC transfusion 2.661 1.491–4.746 0.001
Table 5 Results from the Cox
proportional hazards regression
analysis on the association
between RBC transfusion and
duration of mechanical
ventilation (n = 123 patients).
Adjustments were made for age,
PIM probability of death, mean
TISS-28 score during the first
48 h of PICU admission,
post-operative admission,





from Fig. 1. Mortality rates were equally distributed
among patients with a Hb < 9 g/dl or ≥ 9 g/dl [2 of 36
(5.6%) vs. 14 of 225 (6.2%), p = NS)]. This was also noted
for patients with a Hb < 7 g/dl or ≥ 7 g/dl [1 of 7 (14.3%)
vs. 15 of 254 (5.9%), p = NS]; however, we did observe
a dose-outcome association between the number of RBC
transfusions and mortality (p = 0.002), which is depicted
in Fig. 2.
Additionally, transfused patients required prolonged
ventilatory support (11.1 ± 1.8 vs. 3.2 ± 0.3 days,
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Fig. 3 Standardized mortality
rate (SMR) of transfused and
non-transfused patients
according to five PIM
probability of death strata. The
SMR is calculated by dividing
the number of observed deaths
by the number of expected
deaths. The number of expected
deaths was obtained from the
Dutch Working Group on
Pediatric Intensive Care
Evaluation (PICE). N/A, not
applicable
Variable Hazard 95% CI p-value
PIM probability of death (%) 0.989 0.953–1.027 0.560
Mean TISS-28 first 48 h 0.998 0.984–1.012 0.763
Pre-transfusion Hb concentration (mmol/l) 1.006 0.543–1.863 0.985
Post-operative admission (yes/no) 0.784 0.578–1.063 0.117
Presence of sepsis/malignancy (yes/no) 1.013 0.965–1.062 0.609
RBC transfusion 3.017 1.941–4.691 < 0.001
Table 6 Results from the Cox
proportional hazards regression
analysis on the association
between RBC transfusion and
duration of PICU stay (n = 278
patients). Adjustments were
made for age, PIM probability of
death, mean TISS-28 score
during the first 48 h of PICU
admission, post-operative





p < 0.001), and prolonged infusion of vaso-active
agents (8.2 ± 1.8 vs. 2.8 ± 0.6 days, p < 0.01). Finally,
a prolonged PICU stay (13.0 ± 1.8 vs. 3.2 ± 0.2 days,
p < 0.001) among transfused patients was found.
Fig. 3 shows the SMR among transfused and non-
transfused children for the PIM probability of death. We
observed an excess mortality among transfused children,
especially when they had a very low to moderate proba-
bility of death. Similar observations were made among
children with a high probability of death, but the numbers
of patients was limited in these strata.
In additional analyses—one excluding patients ad-
mitted after a surgical procedure, one excluding patients
with a PICU stay less than 2 days were excluded, and
one excluding patients with a high-risk diagnosis (sepsis
or malignancy)—we also noted significant differences in
mortality, duration of MV, duration of vaso-active support,
and PICU stay between transfused and non-transfused pa-
tients (Table 2). Also, when excluding children older than
12 months similar observations between RBC transfusion
and increased morbidity were made.
Multivariate analysis
Tables 3–6 summarize the results from the adjusted
multivariate logistic regression analysis on the primary
outcome measure, and Cox regression analysis on the
association between RBC transfusion and the secondary
outcome measures. Adjustments were made for PIM
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probability of death, mean TISS-28 score during the
first 48 h of PICU admission, post-operative admission,
presence of sepsis and/or malignancy, and pre-transfusion
Hb concentration. From the multivariate logistic regres-
sion analysis it was found that RBC transfusion was
the strongest variable associated with mortality rather
than disease severity reflected by the PIM probability of
death, mean TISS-28, or the pre-transfusion Hb concen-
tration (Table 3). After adjusting for possible confounding
by PIM probability of death and mean TISS-28 score
during the first 48 h of PICU admission, post-operative
admission, and pre-transfusion Hb concentration, it was
found that RBC transfusion was independently associ-
ated with a prolonged duration of vaso-active support
(Table 3), mechanical ventilation (Table 4), and PICU stay
(Table 5).
Discussion
In this observational study we have found that RBC trans-
fusion in a heterogeneous group of critically ill children
was independently associated with increased mortality and
morbidity. Furthermore, we observed a higher mortality
rate in patients with multiple transfusions but could not
find a difference in mortality and pre-transfusion Hb con-
centration. Excess mortality was found among transfused
patients, especially when they were less severely ill as de-
fined by a low PIM probability of death. Similar observa-
tions were found when patients admitted after a surgical
procedure or patients with a PICU stay less than 2 days
were excluded from analysis. The strength of our study is
that with a relatively small number of patients such a strong
association was found. Although there are numerous data
for adults on this subject, to our knowledge, we are the
first to report an association between RBC transfusion and
mortality in critically ill children.
The findings of this study are in agreement with the
observations by Goodman et al. [4]. In this retrospective
cohort study of five PICUs, patients with a pre-transfusion
Hb concentration less than 9 g/dl admitted between 1996
and 1999 were studied. They found an increased duration
of mechanical ventilation, duration of infusion of vaso-
active agents, and prolonged PICU stay among transfused
children. Although in their study mortality rates were
higher in the transfused group (6.9 vs. 0.9%), the number
of deaths were too low (9 in the transfused group and only
1 in the non-transfused group) to study mortality in a multi-
variate analysis. However, our study was methodologically
different compared with the study by Goodman et al. [4].
Because patients with a pre-transfusion Hb greater than
9 g/dl are also (often) transfused, we included all patients
irrespective of the pre-transfusion Hb value [3, 17]. With
this inclusion method we not only support the observations
by Goodman et al. [4] but also observed an even stronger
association, adding more strength to our study.
Our observations are also in agreement with
those made in a heterogeneous group of critically ill
adults [6–16]. In a large prospective observational study
among 1136 critically ill adults admitted to 145 western
European ICUs it was found in multivariate analysis
that mortality was independently associated with ery-
throcyte transfusions, irrespective of admitting SOFA or
APACHE II score [14]. These observations followed up
on the results of a multicenter, randomized controlled trial
including 838 critically ill patients with a Hb less than
9 g/dl, investigating the effect of a restrictive transfusion
strategy (transfusion if the Hb dropped below 7 g/dl)
compared with a liberal transfusion strategy (transfusion
if the Hb dropped below 10 g/dl) [7]. Overall mortality
and length of ICU stay were comparable between the
two treatment arms, indicating that it was safe to apply
a restrictive transfusion strategy. Additional analysis
demonstrated that in patients with an APACHE II score
less than 20 or patients younger than 55 years mortality
was significantly increased among those randomized
to the liberal transfusion strategy. In contrast to the
above-mentioned studies, Vincent and co-workers were
unable to detect an independent association between RBC
transfusion and increased mortality in 3147 critically ill
adults enrolled in the SOAP study [15]. This disagreement
in findings cannot be easily explained.
Although we have found a strong association, it is more
difficult to ascertain a causative relationship with respect
to pathophysiological mechanisms. It is suggested that
RBC transfusions are associated with immunosuppressive
effects and the development of multiple system organ
failure [12, 21, 22]. It is assumed that leukocytes present in
donor blood are responsible for this immunomodulation.
Studies performed in critically ill or injured patients
showing increased morbidity and mortality mainly used
leukocyte-non-depleted standard or buffy-coat RBC
preparations [7, 12, 14, 21]. It therefore seems reasonable
to advocate the use of leukocyte-depleted preparations,
although the effect of these preparations on patient
outcome is not free from scientific debate [21, 23].
Interestingly, despite the fact that patients in our study
were transfused with leukocyte-depleted RBCs, we still
found increased mortality and morbidity independently
associated with erythrocyte transfusion. Additionally,
we have observed a dose-outcome relationship between
the number of RBC transfusions and mortality (Fig. 2)
instead of a relationship between pre-transfusion Hb
concentration and mortality (Fig. 1). Such a relationship
has also been found to be an independent predictor for
post-operative infections, suggesting a dose-relationship
between erythrocyte transfusion and increased morbid-
ity [8]. Our data suggest that the presence of anemia
itself has no effect on mortality, although the lack of
difference in mortality for patients with a low Hb might
be influenced by the fact these patients are probably
more easily transfused. This observation is in contrast to
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findings by Corwin et al. [6]. They observed that anemia
was an independent predictor for mortality among 4892
critically ill adults enrolled in a multi-center observational
cohort study. This difference is most likely differences
in methodology. We have used the first Hb concentration
when patients were not transfused rather than using the
nadir Hb for analysis. Additionally, but more specula-
tively, children might adapt more easily to anemia than
adults.
Treatment of anemia is the main rationale for trans-
fusing critically ill children. It is often thought that sys-
temic oxygen consumption will be improved in critically
ill children when they are transfused; however, this con-
cept has never been proven [17]. In our study we found
that 13.4% of the patients had a Hb below 9.7 g/dl. Also,
our transfusion rate is in accordance with previously re-
ported numbers by others [3]. Based upon this study we
advocate further investigations aimed at defining a suitable
and safe threshold value for Hb used in the decision as to
when to transfuse a critically ill child, stratifying for age,
disease severity, and co-morbidities. At present, such stud-
ies are unavailable but eagerly awaited [24]. From two sur-
veys among pediatric intensivists comprising four scenar-
ios from daily clinical practice, it became clear that there
is a striking variation in Hb threshold to transfuse patients,
especially among children after cardiac surgery or chil-
dren with sepsis [2, 17]. This was confirmed by a prospec-
tive, descriptive single-center study demonstrating that car-
diac disease, severe critical illness defined by admission
PRISM score > 10, and multiple organ dysfunction syn-
drome (MODS) were independent determinants for the de-
cision to transfuse critically ill children [3].
Some limitations of our study must also be mentioned.
Firstly, its retrospective character could have influenced
the availability of the data collected. Nonetheless, data on
both primary and secondary outcomes could be retrieved
for all included patients. Also, because of its retrospective
character, the decision to transfuse was at the discretion
of the attending physician. The decision to transfuse is
often made on a subjective basis when no transfusion
policy is available. Subjective criteria often include being
on a ventilator or on vaso-active support. This leads to
confounding by indication (i. e., severely ill patients or pa-
tients with a low Hb are more easily transfused), a matter
that can ultimately only be resolved by a randomization,
although regression analysis also minimizes confounding
in cohort studies [20]. However, in order to minimize the
effect of confounding by indication, we have adjusted our
observations for the mean TISS-28 score during the first
48 h of admission. TISS-28 accounts for therapeutic and
monitoring interventions, and correlates with nursing man-
power. By doing so, we have attempted to substitute the
subjective decision to transfuse a patient with the TISS-28
because it comprises parameters that are also often used by
the attending physician in the decision making.
Secondly, our study reflects a single-center experience.
This may limit the generalizability of our study, although
our PICU is most likely comparable to other European and
North American PICUs. Additionally, our patient group is
a heterogeneous group of critically ill children, although
this is not different from many adult studies [6, 7, 14, 16].
Furthermore, because of the relatively small number of pa-
tients, no stratification could be made to study the effect
RBC transfusions in a specific kind of illness such as sep-
sis.
Thirdly, we did not incorporate data on organ dys-
function upon PICU admission as a variable itself in the
multivariate model. We feel that the presence of organ
dysfunction noted only upon PICU admission, instead of
daily assessment, may be less predictive for outcome of the
patient.
Fourthly, in addition to a full multivariate logistic re-
gression analysis, we also performed bivariate logistic re-
gression analysis because the number of outcome events
per independent variable (EPV) might be too low, result-
ing in a unreliable model [25]. Importantly, as with any
multivariate analysis, causality between an event and the
outcome cannot be fully determined, as there might very
well be a confounder that is associated with the outcome
that has not been detected by, for instance, the PIM proba-
bility of death or mean TISS-28.
Finally, RBC transfusions prior to PICU admission but
related to the current condition of the patient, for instance,
transfusions in the operating room, were not included in
the analysis; however, in an attempt to eliminate this pos-
sible confounding, we performed an additional analysis ex-
cluding patients who were admitted after a surgical proce-
dure. From this analysis we observed similar independent
associations between RBC transfusion and mortality and
morbidity.
Conclusion
In this retrospective single-center cohort study RBC
transfusion was independently associated with increased
mortality and prolonged duration of mechanical venti-
lation, infusion of vaso-active agents, and PICU stay.
Higher mortality rates were found among patients with
multiple transfusions. Our observations, although they
should by confirmed by others, warrants the identification
of a suitable and safe threshold value for hemoglobin to
determine when to transfuse critically ill children.
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